Thursday, November 19, 2026
  • Home
  • About us
  • Privacy policy
  • Advertise with us
  • Contact us
Fii News Logo
No Result
View All Result
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
  • ASEANFastest Growing
Newsletter
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
  • ASEANFastest Growing
Fiinews
No Result
View All Result
Home Manufacturing

Manufacturing: VAV upgrades Ratnagiri facility to meet egg yolk lecithin demand

Fiinews by Fiinews
April 25, 2024
in Manufacturing
Reading Time: 2 mins read
A A
0
Vav Ratnagiri Facility

VAV Ratnagiri facility.

0
SHARES
23
VIEWS
LinkedinShare on Twitter

Kedia reports rising demand for egg lecithin from propofol manufacturers

VAV Lipids, India’s leading biopharmaceuticals and speciality ingredient manufacturer, has announced that its upgraded facility at Ratnagiri can meet the rising demand for egg yolk lecithin (egg phospholipids), a key pharmaceutical ingredient for the global market of about US$4,978 million with a projected CAGR of 3.3%.

Egg phospholipids are used in formulating parenteral fat emulsions like anaesthesia drug propofol and total parenteral nutrition formulas, said the Mumbai-headquartered group https://pharmaceuticals.gov.in/ .

VAV’s upgraded EU cGMP-certified manufacturing facility at Ratnagiri, India, can produce 6,000 kilograms (6 tonnes) of egg lecithin annually. This is about 7% of the estimated annual global demand of 85,000 kilograms (85 tonnes).  

The development puts VAV and India on the global list of select suppliers for this high-grade ingredient https://www.biopharmadive.com/ .

Propofol is an intravenous medication used for inducing anaesthesia before surgery. Propofol formulations contain natural triglycerides like soybean oil and egg lecithin, a fatty substance from egg yolk. Both are crucial ingredients that enhance the biocompatibility of the medication.

Speaking about the demand for high grade ingredients, VAV https://vav.in/ Managing Director Arun Kedia said on 23 Apr, “Propofol is an important medication as it dominates the general anaesthesia market.

“We have seen a rising demand for egg lecithin from propofol manufacturers not only from India but all over the world. I am happy that VAV has stepped up to fulfil their requirements, thus ensuring a robust supply chain.”

According to a report published online on the general anaesthesia market, propofol leads the segment with over 25% market share. The report estimates the global general anaesthesia drugs market size to be about US$4,978 million with a projected CAGR of 3.3%.

Other reports suggest that the global egg yolk lecithin Market may reach US$386.6 million by 2030 with a CAGR of 6.4%.

The biopharmaceutical company manufactures plant phospholipids (LECIVA), egg phospholipids (LIPOVA), synthetic phospholipids, and neutral lipids. The other products include APIs and specialty proteins. 

VAV’s high-grade phospholipids and lecithin are functional ingredients in developing novel drugs and biologics delivery systems (NDDS).

Pharmaceutical companies use its high-quality lipids and lecithin to create multiple drug and biologics delivery projects. These include applications of lipids in developing vaccines, anaesthesia and formulations, cancer therapy based on liposomes, and novel drug delivery systems for treating several diseases. The products are also used in skincare, personal care and hair care products. Fiinews.com

Tags: VAV Lipids
ShareTweetShare

Related Posts

Vikram Solar
Manufacturing

Manufacture: TN facility to produce from Dec 2026

by Fiinews
November 16, 2026
0
18

Vikram to set up 9 GW of backward-integrated ingot and wafer capacity Kolkata-headquartered Vikram Solar Limited says its 9-GW N-type...

ISNT
Manufacturing

Manufacture: Minister wants strengthened NDT ecosystem

by Fiinews
November 17, 2026
0
17

Public Sector Undertakings, private manufacturers, start-ups and MSMEs have important role to play defence technology Defence Minister Rajnath Singh has...

NITI Aayog

Manufacture: PLI successful, says NITI Aayog

November 14, 2026
17
Zetsol

Manufacture: 22 bids received for ACC facilities

November 14, 2026
22
Ntpc

Manufacture: NTPC to make urea-DME from coal

November 11, 2026
17
ISBA

Manufacture: FICCI-EY want productive shipyards

November 11, 2026
18
SBI YONO

Recent News

  • Project: MoD inks contract with Israel Aerospace Industries
  • Market: Urban consumers prefer electric mobility
  • Invest: HZL to double production to 2 mtpa
  • Market: Rootstock expands in India through Conserve
  • Market: HGS-Rackspace to grow in high-value GCCs

Pages

  • About US
  • ADVERTISE ON FIINEWS.COM
  • CONTACT US
  • EVENTS
  • FII-NEWS.COM PDF ARCHIVE
  • Home
  • News
  • PRIVACY POLICY
  • About
  • Advertise
  • Careers
  • Contact us

© 2026 FIINEWS - Design and developed by 7clicksmedia.

No Result
View All Result
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
  • ASEAN

© 2026 FIINEWS - Design and developed by 7clicksmedia.